312 related articles for article (PubMed ID: 9808541)
1. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation.
Burt RK; Traynor AE; Pope R; Schroeder J; Cohen B; Karlin KH; Lobeck L; Goolsby C; Rowlings P; Davis FA; Stefoski D; Terry C; Keever-Taylor C; Rosen S; Vesole D; Fishman M; Brush M; Mujias S; Villa M; Burns WH
Blood; 1998 Nov; 92(10):3505-14. PubMed ID: 9808541
[TBL] [Abstract][Full Text] [Related]
2. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients.
Burt RK; Traynor AE; Cohen B; Karlin KH; Davis FA; Stefoski D; Terry C; Lobeck L; Russell EJ; Goolsby C; Rosen S; Gordon LI; Keever-Taylor C; Brush M; Fishman M; Burns WH
Bone Marrow Transplant; 1998 Mar; 21(6):537-41. PubMed ID: 9543056
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
Nash RA; Dansey R; Storek J; Georges GE; Bowen JD; Holmberg LA; Kraft GH; Mayes MD; McDonagh KT; Chen CS; Dipersio J; Lemaistre CF; Pavletic S; Sullivan KM; Sunderhaus J; Furst DE; McSweeney PA
Biol Blood Marrow Transplant; 2003 Sep; 9(9):583-91. PubMed ID: 14506660
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring.
Openshaw H; Lund BT; Kashyap A; Atkinson R; Sniecinski I; Weiner LP; Forman S
Biol Blood Marrow Transplant; 2000; 6(5A):563-75. PubMed ID: 11071262
[TBL] [Abstract][Full Text] [Related]
5. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
[TBL] [Abstract][Full Text] [Related]
6. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease.
Burt RK; Traynor A; Oyama Y; Craig R
Blood; 2003 Mar; 101(5):2064-6. PubMed ID: 12393477
[TBL] [Abstract][Full Text] [Related]
7. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus.
Burt RK; Traynor A; Statkute L; Barr WG; Rosa R; Schroeder J; Verda L; Krosnjar N; Quigley K; Yaung K; Villa Bs M; Takahashi M; Jovanovic B; Oyama Y
JAMA; 2006 Feb; 295(5):527-35. PubMed ID: 16449618
[TBL] [Abstract][Full Text] [Related]
8. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study.
Traynor AE; Schroeder J; Rosa RM; Cheng D; Stefka J; Mujais S; Baker S; Burt RK
Lancet; 2000 Aug; 356(9231):701-7. PubMed ID: 11085688
[TBL] [Abstract][Full Text] [Related]
9. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation.
Statkute L; Verda L; Oyama Y; Traynor A; Villa M; Shook T; Clifton R; Jovanovic B; Satkus J; Loh Y; Quigley K; Yaung K; Gonda E; Krosnjar N; Spahovic D; Burt RK
Bone Marrow Transplant; 2007 Mar; 39(6):317-29. PubMed ID: 17277794
[TBL] [Abstract][Full Text] [Related]
10. High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus.
Lisukov IA; Sizikova SA; Kulagin AD; Kruchkova IV; Gilevich AV; Konenkova LP; Zonova EV; Chernykh ER; Leplina OY; Sentyakova TN; Demin AA; Kozlov VA
Lupus; 2004; 13(2):89-94. PubMed ID: 14995000
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study.
Farge D; Marolleau JP; Zohar S; Marjanovic Z; Cabane J; Mounier N; Hachulla E; Philippe P; Sibilia J; Rabian C; Chevret S; Gluckman E;
Br J Haematol; 2002 Dec; 119(3):726-39. PubMed ID: 12437652
[TBL] [Abstract][Full Text] [Related]
12. A pilot trial for severe, refractory systemic autoimmune disease with stem cell transplantation.
Leng XM; Zhao Y; Zhou DB; Situ H; Li TS; Shen T; Zhao YQ; Zeng XF; Zhang FC; Dong Y; Tang FL
Chin Med Sci J; 2005 Sep; 20(3):159-65. PubMed ID: 16261884
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
14. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.
Lemoli RM; Fortuna A; Motta MR; Rizzi S; Giudice V; Nannetti A; Martinelli G; Cavo M; Amabile M; Mangianti S; Fogli M; Conte R; Tura S
Blood; 1996 Feb; 87(4):1625-34. PubMed ID: 8608257
[TBL] [Abstract][Full Text] [Related]
15. Haematopoietic stem cell transplantation for active systemic lupus erythematosus.
Traynor A; Burt RK
Rheumatology (Oxford); 1999 Aug; 38(8):767-72. PubMed ID: 10501431
[TBL] [Abstract][Full Text] [Related]
16. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma.
Negrin RS; Kusnierz-Glaz CR; Still BJ; Schriber JR; Chao NJ; Long GD; Hoyle C; Hu WW; Horning SJ; Brown BW
Blood; 1995 Jun; 85(11):3334-41. PubMed ID: 7538824
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of severe systemic autoimmune diseases with autologous peripheral blood stem cell transplantation].
Zhao Y; Zhou DB; Leng XM; Wang SJ; Li TS; Duan Y; Shen T; Zhao YQ; Zhang JP; Bai LJ; Cui W; Zhang FQ; Zeng XF; Zhang FC; Dong Y; Tang FL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2077-81. PubMed ID: 15730620
[TBL] [Abstract][Full Text] [Related]
19. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.
Hill GR; Morris ES; Fuery M; Hutchins C; Butler J; Grigg A; Roberts A; Bradstock K; Szer J; Kennedy G; Morton J; Durrant S
Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]